NGM Biopharmaceuticals Inc.
News
NGM Bio Announces Closing of Tender Offer
Globe Newswire SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. ( NGM Bio ) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics...\n more…
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, NGM
Globe Newswire NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...\n more…
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meet
Globe Newswire SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...\n more…
NGM Biopharmaceuticals (NASDAQ:NGM) Rating Lowered to Market Perform at Raymond James
Ticker Report Raymond James cut shares of NGM Biopharmaceuticals (NASDAQ:NGM Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday, MarketBeat Ratings...\n more…